PRAX
Praxis Precision Medicines Inc

1,707
Mkt Cap
$8.31B
Volume
966,672.00
52W High
$356.00
52W Low
$26.70
PE Ratio
-22.15
PRAX Fundamentals
Price
$298.31
Prev Close
$297.50
Open
$295.67
50D MA
$312.99
Beta
0.95
Avg. Volume
446,697.88
EPS (Annual)
-$13.48
P/B
8.56
Rev/Employee
$0.00
$6,033.81
Loading...
Loading...
News
all
press releases
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit
Key Points5AM Venture Management sold 170,000 shares of Praxis Precision Medicines in the fourth quarter...
Nasdaq News: Markets·4d ago
News Placeholder
More News
News Placeholder
Algert Global LLC Increases Stock Position in Praxis Precision Medicines, Inc. $PRAX
Algert Global LLC boosted its position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 483.3% in the third quarter, according to the company in its most recent 13F filing...
MarketBeat·5d ago
News Placeholder
HighVista Strategies LLC Has $5.04 Million Stock Position in Praxis Precision Medicines, Inc. $PRAX
HighVista Strategies LLC raised its stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 41.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·6d ago
News Placeholder
Praxis Precision Medicines, Inc. $PRAX Shares Sold by B Group Inc.
B Group Inc. trimmed its holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 10.0% during the third quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·8d ago
News Placeholder
Vanguard Group Inc. Increases Stock Position in Praxis Precision Medicines, Inc. $PRAX
Vanguard Group Inc. lifted its stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 4.2% in the third quarter, according to its most recent Form 13F filing with the Securities...
MarketBeat·15d ago
News Placeholder
Praxis Precision Medicines, Inc. $PRAX Shares Bought by Rafferty Asset Management LLC
Rafferty Asset Management LLC lifted its position in shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 51.5% in the third quarter, according to its most recent filing with the...
MarketBeat·16d ago
News Placeholder
Praxis Precision Medicines, Inc. $PRAX Shares Sold by TD Asset Management Inc
TD Asset Management Inc cut its stake in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 36.1% in the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·17d ago
News Placeholder
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Recommendation of "Moderate Buy" from Analysts
Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Get Free Report) has received an average recommendation of "Moderate Buy" from the nineteen brokerages that are covering the stock, Marketbeat reports...
MarketBeat·17d ago
News Placeholder
GSA Capital Partners LLP Trims Stock Position in Praxis Precision Medicines, Inc. $PRAX
GSA Capital Partners LLP cut its position in Praxis Precision Medicines, Inc. (NASDAQ:PRAX - Free Report) by 52.2% during the 3rd quarter, according to its most recent 13F filing with the Securities...
MarketBeat·22d ago
News Placeholder
Praxis Precision Medicines (NASDAQ:PRAX) Raised to Strong-Buy at Wolfe Research
Wolfe Research raised shares of Praxis Precision Medicines to a "strong-buy" rating in a report on Monday...
MarketBeat·25d ago
<
1
2
...
>

Latest PRAX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.